It has been shown that MLN4924 successfully truncates NF-κB pathway activity, B-CLL cell survival and chemoresistance in an in vitro co-culture model that mimics the lymph node microenvironment. This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.